A milestone event for the UK and European industry. MGC Pharmaceuticals‘ stock price is excepted to rise after its pre-market placement was markedly oversubscribed. The company’s 441m shares were placed at £0.01475 – giving it a value of £6.5m. The two dozen-or-so initial investors were chosen from scores who offered more than £10m. Speaking to BusinessCann, Roby Zomer, Co-Founder, and Managing Director said: “We are aware we are the first, that was our target and we have worked hard over the last 18 months to achieve that.” Opening The Door “It’s a great achievement and there will be many more. We are now opening the door for the others to follow. We have undertaken the initial work and established the benchmarks to define what is required to be listed.”
Peter Mccusker, Cannabis Business Executive – Cannabis and Marijuana industry news, 02/09/2021 21:27:00